Definitive Healthcare Corp.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY September 30, 2022 |
|---|---|---|---|---|---|
| Revenue | $241.5M | $252.2M | $251.4M | $222.7M | — |
| Gross profit | $183.3M | $197.5M | $203.9M | $180.0M | — |
| Operating income | -$224.3M | -$710.8M | -$329.8M | -$44.0M | — |
| Operating expenses | $407.5M | $908.3M | $533.7M | $224.1M | — |
| Cost of revenue | $58.2M | $54.7M | $47.5M | $42.6M | — |
| Cash from operations | $53.8M | $58.2M | $41.2M | $35.6M | — |
| Capital expenditure | $16.7M | $12.3M | $3.0M | $8.3M | — |
| Free cash flow | $37.1M | $45.9M | $38.2M | $27.3M | — |
| Share repurchases | $49.5M | $22.4M | $0 | $0 | — |
| Impairments | $196.1M | $1.2M | $287.4M | $0 | — |
| Total assets | $735.5M | $1.1B | $1.8B | $2.1B | $2.1B |
| Total liabilities | $356.5M | $482.2M | $626.7M | $640.7M | $648.3M |
Shares outstanding 105.5M · Free float 16.9%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.